Cutler Group’s Gilead Sciences GILD Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2023
Q2 | – | Sell |
-8,600
| Closed | -$14K | – | 3798 |
|
|
2023
Q1 | $14K | Sell |
8,600
-49,600
| -85% | -$4.11M | ﹤0.01% | 2109 |
|
|
2022
Q4 | $123K | Sell |
58,200
-14,600
| -20% | -$1.16M | 0.01% | 1040 |
|
|
2022
Q3 | $59K | Buy |
72,800
+49,500
| +212% | +$3.12M | ﹤0.01% | 1773 |
|
|
2022
Q2 | $51K | Sell |
23,300
-93,800
| -80% | -$5.81M | ﹤0.01% | 1935 |
|
|
2022
Q1 | $71K | Buy |
117,100
+50,500
| +76% | +$3.23M | ﹤0.01% | 1957 |
|
|
2021
Q4 | $305K | Sell |
66,600
-85,000
| -56% | -$5.85M | 0.01% | 1028 |
|
|
2021
Q3 | $1.04M | Buy |
151,600
+106,900
| +239% | +$7.51M | 0.05% | 449 |
|
|
2021
Q2 | $305K | Buy |
44,700
+38,400
| +610% | +$2.56M | 0.01% | 1047 |
|
|
2021
Q1 | $60K | Sell |
6,300
-3,900
| -38% | -$251K | ﹤0.01% | 2210 |
|
|
2020
Q4 | $1K | Sell |
10,200
-2,400
| -19% | -$145K | ﹤0.01% | 4445 |
|
|
2020
Q3 | $12K | Sell |
12,600
-1,100
| -8% | -$76.3K | ﹤0.01% | 2853 |
|
|
2020
Q2 | $52K | Buy |
13,700
+800
| +6% | +$61.3K | ﹤0.01% | 1712 |
|
|
2020
Q1 | $69K | Sell |
12,900
-21,100
| -62% | -$1.46M | ﹤0.01% | 1546 |
|
|
2019
Q4 | $67K | Buy |
34,000
+16,800
| +98% | +$1.09M | ﹤0.01% | 1428 |
|
|
2019
Q3 | $6K | Sell |
17,200
-2,400
| -12% | -$157K | ﹤0.01% | 2913 |
|
|
2019
Q2 | $20K | Buy |
19,600
+12,000
| +158% | +$789K | ﹤0.01% | 2206 |
|
|
2019
Q1 | $4K | Sell |
7,600
-95,500
| -93% | -$6.35M | ﹤0.01% | 3037 |
|
|
2018
Q4 | $147K | Buy |
103,100
+91,400
| +781% | +$6.39M | 0.01% | 803 |
|
|
2018
Q3 | $43K | Sell |
11,700
-38,200
| -77% | -$2.88M | ﹤0.01% | 1697 |
|
|
2018
Q2 | $112K | Buy |
49,900
+42,600
| +584% | +$3.01M | 0.01% | 1080 |
|
|
2018
Q1 | $27K | Sell |
7,300
-109,100
| -94% | -$8.67M | ﹤0.01% | 2068 |
|
|
2017
Q4 | $25K | Sell |
116,400
-24,500
| -17% | -$1.86M | ﹤0.01% | 2372 |
|
|
2017
Q3 | $503K | Buy |
140,900
+78,300
| +125% | +$5.99M | 0.02% | 658 |
|
|
2017
Q2 | $82K | Sell |
62,600
-35,700
| -36% | -$2.38M | ﹤0.01% | 2035 |
|
|
2017
Q1 | $81K | Sell |
98,300
-299,600
| -75% | -$21.1M | ﹤0.01% | 1934 |
|
|
2016
Q4 | $126K | Buy |
397,900
+148,200
| +59% | +$11M | ﹤0.01% | 1697 |
|
|
2016
Q3 | $111K | Buy |
249,700
+108,300
| +77% | +$8.8M | 0.01% | 1717 |
|
|
2016
Q2 | $175K | Sell |
141,400
-63,000
| -31% | -$5.59M | 0.01% | 1217 |
|
|
2016
Q1 | $1.8M | Buy |
204,400
+25,700
| +14% | +$2.32M | 0.12% | 136 |
|
|
2015
Q4 | $185K | Buy |
+178,700
| New | +$18.6M | 0.01% | 1245 |
|
Other funds holding GILD
Cutler Group's GILD Position: Q1 2023 in Review
Cutler Group sold out of Gilead Sciences (GILD) in Q1 2023, closing a stake of 20,570 shares — an estimated $1.7M sold.
Cutler Group first reported a position in GILD in Q4 2015 and held it in 27 quarters. The position peaked at $17.9M in Q2 2016. 1,735 funds tracked by Wall St. Rank hold GILD as of Q1 2023.
- Cutler Group reported no remaining Gilead Sciences position as of Q1 2023 after selling out during the quarter.
- Cutler Group sold 20,570 Gilead Sciences shares in Q1 2023, an estimated $1.7M.
- Cutler Group first reported a position in Gilead Sciences in Q4 2015 and held it in 27 quarters.
- Cutler Group's Gilead Sciences position peaked at $17.9M in Q2 2016.
- 1,735 funds tracked by Wall St. Rank held Gilead Sciences as of Q1 2023.
Based on Cutler Group's 13F filing for Q1 2023, filed 1 May 2023.